STAGE II BREAST CANCER
Clinical trials for STAGE II BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE II BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE II BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Patient-Made vaccine to train immune system against breast cancer
Disease control OngoingThis early-phase study is testing a personalized vaccine for people with HER2-positive breast cancer. The vaccine is made from the patient's own immune cells and is designed to teach the body's immune system to attack the cancer. Researchers are giving the vaccine alongside stand…
Matched conditions: STAGE II BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested to shrink tumors before breast cancer surgery
Disease control OngoingThis study compares two different drug combinations given before surgery to shrink tumors in people with stage II-III HER2-positive breast cancer. About 174 participants were randomly assigned to receive either a newer drug combination (margetuximab) or the standard combination (…
Matched conditions: STAGE II BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough breast cancer: trial tests Post-Surgery drug options
Disease control OngoingThis study is for patients with a specific, aggressive type of breast cancer (triple-negative, basal-like) where cancer cells remain after initial chemotherapy and surgery. It aims to find out which of two follow-up chemotherapy drugs—platinum-based drugs (cisplatin/carboplatin) …
Matched conditions: STAGE II BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Testing a Two-Pronged attack on breast cancer before surgery
Disease control OngoingThis study tested a treatment plan for people with early-stage breast cancer who had not yet had surgery. The goal was to see if giving strong chemotherapy before surgery, with or without the drug trastuzumab (Herceptin), could shrink tumors effectively and be well-tolerated. Res…
Matched conditions: STAGE II BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hormone therapy combinations tested to shrink breast tumors before surgery
Disease control OngoingThis large study compares different hormone therapy approaches given before surgery to shrink breast cancer tumors in postmenopausal women. Researchers are testing whether newer drug combinations work better than the current standard treatment at controlling cancer growth and pre…
Matched conditions: STAGE II BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Shorter radiation course tested for breast cancer patients
Disease control OngoingThis large study is comparing two different schedules of radiation therapy given after mastectomy to prevent breast cancer from coming back. It is testing if a shorter 3-4 week schedule is as safe for breast reconstruction and works as well as the standard 5-6 week schedule. The …
Matched conditions: STAGE II BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Can exercise stop Cancer's return? new study tests sweat as medicine
Prevention OngoingThis study is testing whether regular aerobic exercise can prevent cancer from returning in people who have already been treated. Researchers are working with 33 people who have had breast, prostate, or colorectal cancer to find the right amount of weekly exercise that safely low…
Matched conditions: STAGE II BREAST CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Mar 12, 2026 13:52 UTC